// App-Quantinova.ai

4810 : Histone deacetylase 2 is a potential determinant of the sensitivity of hepatocellular carcinoma cells to sorafenib

Researchers

Presenter

  • Hyung Seok Kim

Principal Investigators

  • Jung Woo Eun

  • Qingyu Shen

  • Woo Chan Shin

  • Hee Doo Yang

  • Sang Yeon Kim

  • Suk Woo Nam

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Epidermal growth factor

  • Extracellular signal-regulated kinase

  • Histone Deacetylase 2

Drug/Treatment

  • Valproic Acid

  • Valproate

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved